Group In Burnaby News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Group in burnaby. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Group In Burnaby Today - Breaking & Trending Today

First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide

MELBOURNE, Australia, May 2, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged. ....

North Vancouver , British Columbia , New Zealand , United States , Kyahn Williamson , Kevin Richardson , Philip Cohen , Public Health Agency Of Canada , Telix Pharmaceuticals , Corporate Communications , Australian Securities Exchange , Health Canada , Australian Therapeutic Goods Administration , Group In Burnaby , Drug Administration , Nuclear Medicine , Telix Pharmaceuticals Limited , Division Head , Isologic Innovative Radiopharmaceuticals , Lions Gate Hospital , Chief Executive Officer , Telix Americas , Western Canada , Health Agency ,

First Patients in Canada Imaged with Illuccix: Now Commercially Available Nationwide

MELBOURNE, Australia, May 2, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces first patients have been imaged in Canada with its commercially available prostate cancer imaging agent, Illuccix [kit for the preparation of gallium (68Ga) PSMA-11 for intravenous injection]. With Illuccix now available nationwide in Canada through Telix's partner Isologic Innovative Radiopharmaceuticals (Isologic), INITIO Medical Group in Burnaby, BC (INITIO) became one of the first sites to administer this novel PSMA-PET imaging agent that can help healthcare professionals diagnose the stage and spread of prostate cancer - an important step for men with this disease. Illuccix, after radiolabeling with gallium (68Ga), is indicated for use with positron emission tomography (PET) of prostate specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are suitable for initial definitive therapy; with suspected re ....

United States , New Zealand , North Vancouver , British Columbia , Philip Cohen , Kevin Richardson , Andre Gagnon , Kyahn Williamson , Telix Pharmaceuticals Limited , Health Canada , Drug Administration , Group In Burnaby , Australian Securities Exchange , Telix Pharmaceuticals , Australian Therapeutic Goods Administration , Nuclear Medicine , Public Health Agency Of Canada , Corporate Communications , Division Head , Isologic Innovative Radiopharmaceuticals , Lions Gate Hospital , Chief Executive Officer , Telix Americas , Western Canada , Health Agency , May 2 ,

First Patients in Canada Imaged with Illuccix®: Now Commercially Available Nationwide

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces first patients have been imaged in Canada with its commercially. ....

New Zealand , British Columbia , North Vancouver , United States , United Kingdom , Philip Cohen , Kevin Richardson , Kyahn Williamson , Australian Securities Exchange , Nuclear Medicine , Division Head , Telix Pharmaceuticals , Public Health Agency Of Canada , Australian Therapeutic Goods Administration , Corporate Communications , Health Canada , Telix Pharmaceuticals Limited , Group In Burnaby , Drug Administration , Isologic Innovative Radiopharmaceuticals , Lions Gate Hospital , Chief Executive Officer , Telix Americas , Western Canada , Health Agency ,